Figure 5
From: Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation
TG is strongly correlated with the antibody and antibody-related lesions: the incidence of HLA antibodies ( HLA-I antibodies: 30% vs. 4.3%, P = 0.018; HLA-II antibodies: 56.7% vs. 17.4%, P = 0.004), PTC C4d deposition (69.8% vs. 32.6%, P = 0.001), PTC inflammation (93.0% vs. 34.9%, P < 0.001) and glomerulitis (93.0% vs. 62.8%, P = 0.001) were higher in TG patients.